3 completed, 1 not yet recruiting. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 3, Not yet recruiting 1 |
Follow Z 338: new trials by email Literature Review of Z 338 trials Research Report on Z 338
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Acotiamide vs Itopride in Postprandial Distress Syndrome Acotiamide - Postprandial Distress Syndrome | Phase 3 | Not yet recruiting | Getz Pharma | 152 | 2025-10-30 | 2025-09-23 |
| Phase III, Long-term, Open-label Safety Study of Z-338 Z-338 - Dyspepsia | Phase 3 | Completed | Zeria Pharmaceutical | 207 | 2014-03-01 | 2017-06-28 |
| To Verify the Efficacy of Z-338 in Subjects With Functional Dyspepsia Z-338, Placebo - Functional Dyspepsia | Phase 3 | Completed | Zeria Pharmaceutical | 820 | 2008-09-01 | 2010-11-23 |
| A Long-term, Open-label, Uncontrolled Trial of YM443 (Z-338) in Patients With Functional Dyspepsia YM443 - Dyspepsia, Functional Dyspepsia | Phase 3 | Completed | Astellas Pharma Inc | 412 | 2008-08-01 | 2014-10-29 |
Dyspepsia (2) · Signs and Symptoms, Digestive (1)
Zeria Pharmaceutical (2) · Astellas Pharma Inc (1) · Getz Pharma (1)
Japan (2) · Belgium (1) · Bulgaria (1) · Latvia (1) · Lithuania (1) · Romania (1) · Russia (1) · Slovakia (1) · Sweden (1) · Ukraine (1) · United Kingdom (1)
Jan Tack, MD, PhD (1) · Michio Hongo, Professor (1) · Prof. Dr. Muahmmad Umar, MBBS, FCPS, FACG, AGAF, FRCP (1)